Amerise Biosciences Approves Financial Statements and Appoints Whole-time Director and CFO
Amerise Biosciences Ltd 路 Annual General Meeting 路 24 Sept 2026, 9:57 pm
Amerise Biosciences Approves Financial Statements and Appoints Whole-time Director and CFO Amerise Biosciences Limited transacted and approved key resolutions at its 41st Annual General Meeting held on 24th Sep'26. Shareholders approved the adoption of audited financial statements for the financial year ended 31st Mar'26, along with reports from directors and auditors. Additionally, shareholders cleared an ordinary resolution appointing Mr. Albert Hines (DIN: 10742692) as Whole-time Director and Chief Financial Officer of the company. Detailed voting results under Regulation 44(3) are being submitted separately.
Original exchange filing (PDF)
More announcements from Amerise Biosciences Ltd
- PFA 路 30 Oct 2026
- Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors .... 路 30 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd 路 30 Oct 2026
- Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Pursuant to Regulation .... 路 30 Oct 2026
- PFA 路 10 Oct 2026
- PFA 路 24 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... 路 01 Sept 2026
- PFA 路 01 Sept 2026
